Literature DB >> 9013350

HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Response to interferon therapy.

S D Malnick1, Y Abend, E Evron, Z M Sthoeger.   

Abstract

A 54-year-old man with chronic hepatitis C virus (HCV) developed quadrihemianopsia caused by lacunar brain infarction. Extensive evaluation revealed high titers of anticardiolipin antibodies (ACA). Following interferon treatment (6 x 10(6), three times a week for 2 months and 3 x 10(6) for another 7 months), liver transaminase levels decreased to normal, HCV RNA in blood was no longer detectable, concomitantly with the disappearance of the ACA. The patient remained clinically stable without evidence for either HCV activity (RNA) or ACA or further thromboembolic events.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013350     DOI: 10.1097/00004836-199701000-00009

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

Review 1.  Antiphospholipid antibodies and infections.

Authors:  R A Asherson; R Cervera
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 2.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 3.  Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.

Authors:  Luigi Elio Adinolfi; Riccardo Nevola; Giacomo Lus; Luciano Restivo; Barbara Guerrera; Ciro Romano; Rosa Zampino; Luca Rinaldi; Ausilia Sellitto; Mauro Giordano; Aldo Marrone
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

4.  Hepatitis C and recurrent treatment-resistant acute ischemic stroke.

Authors:  Aneeta Saxsena; Joseph Tarsia; Casey Dunn; Aimee Aysenne; Basil Shah; David F Moore
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

5.  Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis.

Authors:  G V Papatheodoridis; E Papakonstantinou; E Andrioti; E Cholongitas; K Petraki; I Kontopoulou; S J Hadziyannis
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 6.  Hepatitis C virus and neurological damage.

Authors:  Shilu Mathew; Muhammed Faheem; Sara M Ibrahim; Waqas Iqbal; Bisma Rauff; Kaneez Fatima; Ishtiaq Qadri
Journal:  World J Hepatol       Date:  2016-04-28

Review 7.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

Review 8.  HCV-related nervous system disorders.

Authors:  Salvatore Monaco; Sergio Ferrari; Alberto Gajofatto; Gianluigi Zanusso; Sara Mariotto
Journal:  Clin Dev Immunol       Date:  2012-07-30

Review 9.  Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview.

Authors:  Mohd Suhail; Sayed Sartaj Sohrab; Mohammad Amjad Kamal; Esam Ibraheem Azhar
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

Review 10.  Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders.

Authors:  Rita Moretti; Mauro Giuffrè; Nicola Merli; Paola Caruso; Stefano Di Bella; Claudio Tiribelli; Lory Saveria Crocè
Journal:  Brain Sci       Date:  2021-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.